title: Lung function in prematurely born infants after viral lower respiratory tract infections.
abstract: BACKGROUND
  Chronic respiratory morbidity has been reported in prematurely born infants after respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) lower respiratory tract infections (LRTIs). The aim of this study was to determine the impact of viral LRTI on lung function at follow-up of prematurely born infants.
  
  
  METHODS
  Fifty-nine infants born before 32 weeks of gestational age were prospectively followed after neonatal unit discharge. Nasopharyngeal aspirates were obtained when the infants developed LRTIs in hospital or the community. RSV was identified by immunofluorescence and/or culture. In addition, RSV and other viral infections were identified by real time reverse transcription polymerase chain reaction. At a corrected age of 1 year, measurements of lung volume [functional residual capacity (FRC)pleth] and airway resistance (R(aw)) were made by plethysmography, and lung volume was also assessed by helium gas dilution (FRC(He)). Before the measurements, parents completed diary cards for 1 month documenting on a daily basis whether their infant wheezed, coughed, or required bronchodilator therapy.
  
  
  RESULTS
  Twenty-five infants had at least 1 proven RSV LRTI (RSV-positive group). The RSV-positive group compared with the rest of the cohort had similar lung volumes, but significantly higher R(aw) (P = 0.002), more days of wheeze (P < 0.001), and bronchodilator requirement (P = 0.027). Regression analysis also identified that hMPV LRTI was associated with elevated airways resistance at follow-up.
  
  
  CONCLUSIONS
  RSV and hMPV LRTIs in prematurely born infants are associated with abnormal lung function at follow-up.
authors.affiliation: Division of Asthma, Allergy and Lung Biology, MRC-Asthma Centre, King's College London, London, UK.
authors.forename: Simon
authors.initials: S
authors.lastname: Broughton
authors.forename: Karl P
authors.initials: KP
authors.lastname: Sylvester
authors.forename: Grenville
authors.initials: G
authors.lastname: Fox
authors.forename: Mark
authors.initials: M
authors.lastname: Zuckerman
authors.forename: Melvyn
authors.initials: M
authors.lastname: Smith
authors.forename: Anthony D
authors.initials: AD
authors.lastname: Milner
authors.forename: Gerrard F
authors.initials: GF
authors.lastname: Rafferty
authors.forename: Anne
authors.initials: A
authors.lastname: Greenough
mesh_terms: D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature; D007235:Infant, Premature, Diseases / Q000503:physiopathology* / Q000821:virology; D008297:Male; D029121:Metapneumovirus / Q000472:pathogenicity; D018184:Paramyxoviridae Infections / Q000503:physiopathology / Q000821:virology; D012129:Respiratory Function Tests; D018357:Respiratory Syncytial Virus Infections / Q000503:physiopathology / Q000821:virology; D018113:Respiratory Syncytial Virus, Human / Q000472:pathogenicity; D012141:Respiratory Tract Infections / Q000503:physiopathology* / Q000821:virology